Advances in precision medicine for breast cancer in 2025
Jenna Canzoniero, MD, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, provides an overview of recent advancements in precision medicine for breast cancer, emphasizing the growing role of targeted therapies and the critical need for molecular diagnostic tools. Strategies for aligning specific treatments with diagnostic tests to optimize patient outcomes are being developed, and recently presented emerging therapies highlight the importance of tailoring interventions to individual patient profiles. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
